Roche and Bio-Rad Enter Into Global Quality Control Partnership
By LabMedica International staff writers Posted on 10 Mar 2021 |
Image: Roche and Bio-Rad Enter Into Global Quality Control Partnership (Photo courtesy of Bio-Rad Laboratories)
Roche (Basel, Switzerland) and Bio-Rad Laboratories (Hercules, CA, USA) have entered into a global partnership to provide their customers access to Bio-Rad's complete line of InteliQ products and Unity QC data management solutions along with customer training and support services.
Bio-Rad offers a broad range of quality controls covering analytes for immunoassay, chemistry, cardiac assessment, immunology, diabetes, coagulation, hematology, blood gas, drugs-of-abuse, and infectious disease testing. The company’s Unity QC data management solutions connect large peer groups of test systems and assay methods to the Unity Interlaboratory Program, enabling labs to compare their results in real time with over 25,000 other labs worldwide.
Through the global partnership, Roche and Bio-Rad will provide InteliQ products, a range of barcoded, load-and-go quality control tubes that provide efficiencies in workflow, in addition to Bio-Rad’s Unity QC data management solutions. The InteliQ products are designed to help streamline a lab's QC workflow with load-and-go efficiency and Unity QC data management solutions that help to reduce turnaround time and increase a laboratory’s analytical performance.
"We are proud to extend our partnership with Roche offering their customers access to our InteliQ line of quality controls and Unity QC data management solutions," said Dara Wright, Bio Rad Clinical Diagnostics Group EVP & President. "This agreement further strengthens and expands the relationship between Bio-Rad, the world’s leading QC supplier, and a leading diagnostic solutions provider."
Related Links:
Roche
Bio-Rad Laboratories
Bio-Rad offers a broad range of quality controls covering analytes for immunoassay, chemistry, cardiac assessment, immunology, diabetes, coagulation, hematology, blood gas, drugs-of-abuse, and infectious disease testing. The company’s Unity QC data management solutions connect large peer groups of test systems and assay methods to the Unity Interlaboratory Program, enabling labs to compare their results in real time with over 25,000 other labs worldwide.
Through the global partnership, Roche and Bio-Rad will provide InteliQ products, a range of barcoded, load-and-go quality control tubes that provide efficiencies in workflow, in addition to Bio-Rad’s Unity QC data management solutions. The InteliQ products are designed to help streamline a lab's QC workflow with load-and-go efficiency and Unity QC data management solutions that help to reduce turnaround time and increase a laboratory’s analytical performance.
"We are proud to extend our partnership with Roche offering their customers access to our InteliQ line of quality controls and Unity QC data management solutions," said Dara Wright, Bio Rad Clinical Diagnostics Group EVP & President. "This agreement further strengthens and expands the relationship between Bio-Rad, the world’s leading QC supplier, and a leading diagnostic solutions provider."
Related Links:
Roche
Bio-Rad Laboratories
Latest Industry News
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus
- AMP Publishes Best Practice Guidance for Slice Testing Approach in Diagnostics